Clinical trial
A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease
NCT02172924 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease
- Lead sponsor
- Karolinska Institutet
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2019
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.